London Genetics, Astrimmune to Develop Biomarkers for Pancreatic Cancer Vaccine

The biomarkers will be used to predict clinical response to an Astrimmune vaccine, which induces antibody production against gastrin.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories